Corporate Banner
Satellite Banner
Technology Networks Header
Tuesday, July 29, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Malvern Specialist to Explore Use of NTA at ISEV 2014
Tuesday, March 11, 2014
Pauline Carnell will discuss NTA use for characterizing extracellular vesicles.

QIAGEN Expands GeneGlobe Web Portal
Tuesday, March 11, 2014
Portal now includes interactive access to extensive genomic content from Ingenuity’s Knowledge Base.

WuXi PharmaTech Purchases an Illumina HiSeq X Ten Sequencing System
Tuesday, March 11, 2014
New investment will enable WuXi's services to expand to population genome scale sequencing.

IBinom Introduces Revolutionary, Fast, Efficient, User-friendly Genomic Data Interpreter
Tuesday, March 11, 2014
The Moscow Startup has released the beta version of a cloud-based SaaS (Software as a Service) solution for NGS (next-generation-sequencing) data interpretation.

Swift Biosciences Launches Accel-NGS™ 2S DNA Library Kit
Monday, March 10, 2014
Product dramatically reduces sample requirements for NGS sample prep.

Dako Further Expands World's Leading Special Stain Solution for Cancer Diagnostics
Tuesday, March 04, 2014
Addition of New Jenner-Wright Giemsa stain to Company’s Dako Artisan™ Link portfolio.

Unilabs and Diagnoplex SA Announce the Swiss Market Launch of Colox
Saturday, March 01, 2014
A non-invasive colon cancer screening test.

Integromics Releases New Version of its qPCR Data Analysis Software
Friday, February 28, 2014
RealTime StatMiner® V5.0 software enhances functionality and improves customer experience.

384-Well Reagent Reservoirs from INTEGRA
Friday, February 28, 2014
Reagent reservoirs offer maximum liquid recovery.

<< 7 8 9 10 11 12 13 >>
Showing Results 91 - 100 of 2496
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv